34th week of 2013 patent applcation highlights part 52 |
Patent application number | Title | Published |
20130217871 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION - The present invention relates to hydroxyalkyl starch conjugates and a method for preparing the same, the hydroxyalkyl starch conjugate comprising a hydroxyalkyl starch derivative and a cytotoxic agent, the cytotoxic agent comprising at least one primary hydroxyl group, wherein the hydroxyalkyl starch is linked via said primary hydroxyl group to the cytotoxic agent. The conjugates according to the present invention have a structure according to the following formula HAS′(-L-M) | 2013-08-22 |
20130217872 | METHOD FOR PRODUCING COMPOSITE GEL BY CROSS-LINKING HYALURONIC ACID AND HYDROXYPROPYL METHYLCELLULOSE - A method for covalently cross-linking hyaluronic acid (HA) and hydroxypropyl methylcellulose (HPMC) by a diepoxide crosslinking agent. The method includes the following steps: a) mixing HA and HPMC in water; b) adding an alkali as a catalyst and a diepoxide as a crosslinking agent; c) neutralizing with hydrochloric acid and dehydrating with ethanol and acetone; and d) drying in vacuum and redissolving in water to obtain an HA-HPMC composite gel. | 2013-08-22 |
20130217873 | METHOD FOR THE PREPARATION OF A PARTICULATE REVERSIBLY CROSSLINKED POLYMERIC MATERIAL - The present invention relates to method for the preparation of a particulate reversibly-crosslinked polymeric material comprising: treating a particulate water-soluble hydroxyl-functional polymer in a liquid phase comprising a solvent mixture in that the hydroxyl-functional polymer is insoluble containing an organic solvent and water; a tetracarboxylic acid dianhydride represented by formula (I), 10 (I) wherein: U and V are independently selected from CH, N and P; 15 X is selected from a single bond, a saturated divalent (C | 2013-08-22 |
20130217874 | METHOD FOR MAKING MACROCYCLES - Disclosed embodiments concern a method for making substantial quantities of desired macrocycles. Disclosed ring closing reactions make the macrocycle with desired olefin geometry in excellent yield and E/Z ratio. Particular embodiments of the current method concern intermediates that are obtained from commercially available starting materials in a small number of steps, thereby illustrating the commercial importance and applicability of the disclosed method. The macrocycle produced by the ring closing reaction can be further derivatized to provide analogs of the macrocyclic compounds. | 2013-08-22 |
20130217875 | PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES - The invention is directed to a process for the preparation of a cyclic carbamate starting with a chiral propargylic alcohol and/or a suitable salt thereof, which is reacted with a cyclisation agent selected from phosgene, diphosgene, triphosgene and mixtures thereof, and in that the reaction is carried out in the presence of an aqueous base, and a water-immiscible organic solvent, said organic solvent mainly comprising at least one compound selected from C | 2013-08-22 |
20130217876 | PHOSPHINE LIGANDS FOR CATALYTIC REACTIONS - The disclosure is directed to: (a) phosphacycle ligands; (b) catalyst compositions comprising phosphacycle ligands; and (c) methods of using such phosphacycle ligands and catalyst compositions in bond forming reactions. | 2013-08-22 |
20130217877 | PARA- OR MESO-FUNCTIONALIZED AROMATIC KETONE COMPOUNDS, PREPARATION METHODS THEREOF, AND PHOTOPOLYMERIZATION INITIATORS COMPRISING THE SAME - The present invention discloses novel aromatic ketone compounds with functional substiution groups at para- or meta positions which can be used as photo-initiators or effective components of photo-initiator mixtures for the photopolymerizations of ethylenically unsaturated systems. The preparation of these compounds is also disclosed. | 2013-08-22 |
20130217878 | (AZA)INDOLIZINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF - (Aza)indolizine derivatives represented by Formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, salts thereof or the like. In Formula (I), 0 to 2 of X | 2013-08-22 |
20130217879 | ENTECAVIR SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF - The present invention relates to a preparation method for a medicine and an intermediate compound thereof, specifically, relates to a preparation method for entecavir, an intermediate compound thereof, and a synthesis method for the intermediate compound. | 2013-08-22 |
20130217880 | PURINONE DERIVATIVE - Compounds represented by general formula (I) (all of the symbols in the formula conform to the definitions in the Description) are compounds that, in addition to having a Btk-selective inhibitory activity, exhibit an excellent metabolic stability and can avoid hepatotoxicity or the like, and as a consequence can provide safe therapeutic agents for diseases in which B cells or mast cells participate. | 2013-08-22 |
20130217881 | NOVEL COMPOUNDS HAVING AUDITORY PROTECTIVE EFFECT - The present invention relates to a compound represented by formula 1 in the present specification or a pharmaceutically acceptable thereof, which inhibits an apoptosis mechanism of auditory hair cells for various ototoxicities leading to deafness, and protects the auditory organ and hearing, a method for preparation thereof, and a composition containing the same. | 2013-08-22 |
20130217882 | ORGANIC COMPOUNDS - A compound of formula IV: | 2013-08-22 |
20130217883 | METHODS OF PRODUCING SULFILIMINE COMPOUNDS - Methods of producing a sulfilimine compound, such as N-cyano-S-methyl-S-[1-(6-trifluoromethyl-3-pyridinyl)ethyl]sulfilimine or other substituted sulfilimine compound. The method includes combining a sulfide compound, cyanamide, a hypochlorite compound, and a base, and oxidizing the sulfide compound to form the sulfilimine compound. The sulfide compound may include a 2-trifluoromethyl-5-(1-substituted)alkyl-thiopyridine compound. The base may include sodium hydroxide. A buffer, such as a phosphate buffer, may, optionally, be used in the reaction. | 2013-08-22 |
20130217884 | ETHYNYLPHENYLAMIDINE COMPOUND OR SALT THEREOF, METHOD FOR PRODUCING SAME, AND FUNGICIDE FOR AGRICULTURAL AND HORTICULTURAL USE - An object of the present invention is to provide a novel fungicide having an excellent fungicidal activity. The compound used as the fungicide of the present invention is an ethynylphenylamidine compound or a salt thereof, the compound being represented by Formula (1): | 2013-08-22 |
20130217885 | PHARMACEUTICAL COMPOSITION CONTAINING OPTICALLY ACTIVE COMPOUND HAVING THROMBOPOIETIN RECEPTOR AGONIST ACTIVITY, AND INTERMEDIATE THEREFOR - An optically active 4-phenylthiazole derivative having a thrombopoietin receptor agonist activity and a pharmaceutical composition containing the present compound as an active ingredient are created, and a platelet production regulating agent which can be orally administered is provided. | 2013-08-22 |
20130217886 | SYNTHESIS OF ENONE INTERMEDIATE - The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides a more efficient route for preparing the enone intermediate. | 2013-08-22 |
20130217887 | Compounds With Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof - Novel compounds and pharmaceutical compositions having MMP inhibitory activity are disclosed, which have been found to be particularly useful in the prevention, treatment and diagnostic imaging of diseases associated with an unpaired activity of MMP, amongst others MMP-2, MMP-8, MMP-9 and/or MMP-13 to name a few. The compounds of the present invention are useful for the prevention, the treatment and the in vivo diagnostic imaging of a range of disease states (inflammatory, malignant and degenerative diseases) where specific matrix metalloproteinases are known to be involved. | 2013-08-22 |
20130217888 | PROCESS FOR PREPARING BENDAMUS TINE HYDROCHLORIDE MONOHYDRATE - The present invention provide processes for the preparation of Bendamustine hydrochloride monohydrate of formula (I) | 2013-08-22 |
20130217889 | NOVEL PHASE TRANSFER CATALYSTS - Compounds of formula (I): wherein R | 2013-08-22 |
20130217890 | METHOD FOR PRODUCING PYRAZOLINONE SALT - A salt represented by formula (4) produced via
| 2013-08-22 |
20130217891 | Telescoping Synthesis of 5-Amino-4-Nitroso-1-Alkyl-1H-Pyrazole Salt - A telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1H-pyrazole salt derivatives of formula (I), the compound (I) itself, and its use as an intermediate in the fabrication of 1-alkyl-4,5-diaminopyrazole salts of general formula (IX). The compounds of formula (IX) can be used as precursor dyes in oxidative hair dye compositions. | 2013-08-22 |
20130217892 | Use Of N-Substituted 2-Pyrrolidone-4-Carboxylic Acid Esters And Solvents - The invention relates to the use of one or more N-substituted 2-pyrrolidone-4-carbonic acid esters of formula (1), where R1 and R2 independently represent linear, branched, or cyclic C1-C6 alkyl, as (a) solvent(s). Said compounds can be used as solvents in industrial applications, e.g. for the production of varnishes and paints, in chemical syntheses, for cleaning or degreasing, in petrochemical processes, in the electronics and photovoltaic industries, or in pesticide preparations, for example. | 2013-08-22 |
20130217893 | METHOD FOR PRODUCING 3,4-DISUBSTITUTED PYRROLIDINE DERIVATIVE - The present invention provides an inexpensive and industrially advantageous method for producing an optically active form of an anti-(3S,4R)-3-alkylcarbamoyl-4-hydroxypyrrolidine derivative or it's enantiomer, which is a key intermediate for producing a high-quality optically active form of (3R,4S)-3-alkylaminomethyl-4-fluoropyrrolidine or it's enantiomer useful as an intermediate for producing pharmaceuticals. | 2013-08-22 |
20130217894 | ORGANIC AMINE SALTS OF AMINOBENZOIC ACID DERIVATIVES AND METHOD FOR PRODUCING SAME - A novel organic amine salt or salt with quaternary ammonium ion of 3-{[((2E)-2-{1-[5-(4-t-butylphenyl)-4-hydroxy-3-thienyl]ethylidene}hydrazino)carbonothioyl]amino}benzoic acid having useful properties as a drug is provided. | 2013-08-22 |
20130217895 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME - The present invention provides a catalyst used for manufacturing an optically active carbonyl compound by selective asymmetric hydrogenation of an α, β-unsaturated carbonyl compound, which is insoluble in a reaction mixture, and a method for manufacturing the corresponding optically active carbonyl compound. Particularly, the invention provides a catalyst for obtaining an optically active citronellal useful as a flavor or fragrance, by selective asymmetric hydrogenation of citral, geranial or neral. The invention relates to a catalyst for asymmetric hydrogenation of an α, β-unsaturated carbonyl compound, which comprises: a powder of at least one metal selected from metals belonging to Group 8 to Group 10 of the Periodic Table, or a metal-supported substance in which the at least one metal is supported on a support; an optically active cyclic nitrogen-containing compound; and an acid, and also relates to a method for manufacturing an optically active carbonyl compound using the same. | 2013-08-22 |
20130217896 | GAS PHASE OXIDATION CATALYST WITH LOW CHARGE TRANSPORT ACTIVATION ENERGY - A catalyst for the gas phase oxidation of organic hydrocarbons comprises a multielement oxide which comprises at least one transition meal such as vanadium, wherein the catalyst has a charge transport activation energy E | 2013-08-22 |
20130217897 | VPO CATALYST WITH LOW VANADIUM OXIDATION STATE FOR MALEIC ANDHYDRIDE PRODUCTION (D#81,745) - An oxidation catalyst comprising vanadium, phosphorus, and oxygen having average vanadium valence less than about 4.10, and a method of preparing such catalyst, is provided. The catalyst has side crush strength of at least about 5 lbs. and improved yield of maleic anhydride from n-butane between about 1% and about 6% absolute. The catalyst is formed by exposing a conventional active VPO catalyst having average vanadium valence between about 4.10 and about 4.40 to an organic solvent having a dielectric constant between about 5 and about 55 under conditions that facilitate an oxidation-reduction reaction, reducing the valence of the vanadium below 4.10. | 2013-08-22 |
20130217898 | METHOD FOR MANUFACTURING ESTER - The present invention relates to a method for manufacturing an ester from a ketone or an aldehyde, which is a reactive substrate, by a Baeyer-Villiger oxidation reaction using hydrogen peroxide, and in this method, as a catalyst, M(BAr | 2013-08-22 |
20130217899 | INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF FINGOLIMOD - The present invention relates to processes for the preparation of (2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride (Fingolimod) and pharmaceutically acceptable salts thereof, and intermediates formed in such processes. | 2013-08-22 |
20130217900 | CHIRAL INTERMEDIATES USEFUL FOR THE PREPARATION OF HYDROXYPHOSPHINE LIGANDS - A compound of formula (I), wherein R | 2013-08-22 |
20130217901 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 4-CHLORO-3-HYDROXYBUTANAL COMPOUND - The invention relates to a method of producing optically active 4-chloro-3-hydroxybutanal compound (2) by reacting chloroacetaldehyde with aldehyde compound (1) in the presence of optically active pyrrolidine compound (5). | 2013-08-22 |
20130217902 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR INHIBITING MAMMALIAN TUMOR CELL PROLIFERATION - Compounds of following general formula (I) and pharmaceutical compositions thereof for inhibiting mammalian tumor cell proliferation are disclosed. In formula (I), n is an integer from 0 to 9. The cell proliferation of breast tumor, ovarian tumor, skin tumor or liver tumor is inhibited by the compounds of the formula (I). | 2013-08-22 |
20130217903 | PROCESS FOR PREPARING A CRYSTALLINE FORM OF HALOBETASOL PROPIONATE - The present invention provides a process for preparing a crystalline form of halobetasol propionate, comprising the step of crystallizing halobetasol propionate from absolute ethanol or a mixture of ethanol and water, wherein the crystalline form of halobetasol propionate is characterized by an x-ray powder diffraction pattern having peaks at 10.0, 11.6, 12.9, 13.4, 14.5, 16.4, 17.6, and 23.5±0.2 degrees 2θ. | 2013-08-22 |
20130217904 | METHOD OF EXTRACTING POLAR LIPIDS AND NEUTRAL LIPIDS WITH TWO SOLVENTS - A method for separating polar lipids and neutral lipids from plant material, in particular, intact algal cells, using an amphipathic solvent set and a hydrophobic solvent set. Some embodiments include dewatering intact algal cells and then extracting polar lipids and neutral lipids from the algal cells. The methods provide for single and multistep extraction processes which allow for efficient separation of algal polar lipids and neutral lipids from a wet algal biomass while avoiding emulsification of extraction mixtures. These polar lipids are high value products which can be used as surfactants, detergents, and food additives. These neutral lipids are also high value products which can be used to generate renewable fuels. | 2013-08-22 |
20130217905 | Regiospecific silicone glycerin polyesters - The present invention is directed to a series of silicone containingpolymeric glyceryl esters that have two different molecular weight ester chains, one solid and one liquid, which when combined into a single molecule make a polymer that is solid, but has very unique flow properties. These materials find applications as additives to formulations in personal care products where there is a desire to have a structured film (provided by the solid fatty group) and flow properties, (provided by the liquid fatty group). These compounds by virtue of their unique structure provide outstanding skin feel. | 2013-08-22 |
20130217906 | DIENE-SELECTIVE HYDROGENATION OF METATHESIS DERIVED OLEFINS AND UNSATURATED ESTERS - Methods are provided for refining natural oil feedstocks and partially hydrogenating polyunsaturated olefins and polyunsaturated esters. The methods comprise reacting the feedstock in the presence of a metathesis catalyst under conditions sufficient to form a metathesized product comprising olefins and esters. In certain embodiments, the methods further comprise separating the polyunsaturated olefins from the polyunsaturated esters in the metathesized product. In certain embodiments, the methods further comprise partially hydrogenating the polyunsaturated olefins in the presence of a hydrogenation catalyst, wherein at least a portion of the polyunsaturated olefins are converted to monounsaturated olefins. In other embodiments, the methods further comprise partially hydrogenating the polyunsaturated esters in the presence of a hydrogenation catalyst, wherein at least a portion of the polyunsaturated esters are converted to monounsaturated esters. | 2013-08-22 |
20130217907 | BRANCHED POLYSILOXANES AND USE OF THESE - Branched polysiloxanes of formula (I) | 2013-08-22 |
20130217908 | STABILISATION OF RADIOPHARMACEUTICAL PRECURSORS - The invention relates to a method for improving stability of radiopharmaceutical precursors, and in particular protected amino acid derivatives which are used as precursors for production of radiolabelled amino acids for use in in vivo imaging procedures such as positron emission tomography (PET). The invention further includes compositions comprising a radiopharmaceutical precursor and a drying agent, and cassettes for automated synthesis apparatus comprising the same. | 2013-08-22 |
20130217909 | PROCESS FOR OBTAINING ACROLEIN BY CATALYTIC DEHYDRATION OF GLYCEROL OR GLYCERIN - A continuous process for obtaining acrolein by catalytic dehydration of glycerol or glycerin, in the presence of an acid catalyst, wherein said process comprises the concomitant regeneration of said catalyst and is carried out in a fluidized bed reactor, said reactor comprising two zones, a first zone, or lower zone, termed catalyst regeneration zone, in which a fluidization gas comprising oxygen is introduced, and a second zone, or upper zone, termed reaction zone, in which the glycerol or glycerin is introduced and converted into acrolein. | 2013-08-22 |
20130217910 | PROCESS FOR THE PREPARATION OF SUBSTITUTED N-(BENZYL)CYCLOPROPANAMINES BY IMINE HYDROGENATION - The present invention relates to a process for the preparation of substituted N-(benzyl)cyclopropanamines of the general formula (II) starting from N-[(aryl)methylene]cyclopropanamine derivatives. The present invention further provides the N-[(arypmethylene]cyclopropanamine derivatives used as starting compounds in this process according to the invention, and their use for the preparation of substituted N (benzyl)cyclopropanamines. | 2013-08-22 |
20130217911 | Method For Producing Acyloxy Benzoic Acids - The invention relates to a method for producing acyloxy benzoic acids of the formula (I), in which R | 2013-08-22 |
20130217912 | PROCESS FOR PREPARING MERCAPTOALKYL CARBOXYLATES - In the acid-catalyzed esterification of mercaptoalkyl alcohols by means of carboxylic acids to form mercaptoalkly carboxylates, formation of undesirable, usually sparingly soluble by-products usually occurs. The process of the invention in the absence of acid catalysts avoids the formation of such by-products. Particularly when the esterification of the invention is carried out as reactive distillation using reactive column and residence vessel, good degrees of conversion can also be obtained without acid catalyst and at the same time the formation of the by-products can be largely avoided. | 2013-08-22 |
20130217913 | Antimalarial Drug Comprising Alaremycin or Derivative Thereof as Active Ingredient - Provided is a preventive and/or therapeutic agent for malaria, comprising, as an active ingredient, 5-acetamido-4-oxo-5-hexenoic acid (Alaremycin) or a derivative thereof. A preventive and/or therapeutic agent for malaria is used which comprises, as an active ingredient, Alaremycin or a derivative thereof represented by formula (I) (wherein R | 2013-08-22 |
20130217914 | PROCESS FOR PRODUCING METHYL METHACRYLATE HAVING REDUCED BIACETYL CONTENT - This invention provides a process for reducing biacetyl in alpha-, beta-unsaturated carboxylic acid esters, particularly in acrylic or methacrylic (hereinafter “(meth)acrylic”) esters, which comprise low levels of weak acid. | 2013-08-22 |
20130217915 | Catalyst and Method for Producing Acrylic Acid - The present invention relates to a method for producing acrylic acid through vapor-phase contact oxidation of acrolein, wherein a reactor tube is divided into at least two catalyst layers, and catalysts having a higher activity are charged in the reactor tube sequentially toward an outlet port side from a material source gas inlet port side for a reaction therein to give acrylic acid, and wherein a catalyst activity-controlling method is a method comprising: a step of mixing a molybdenum-containing compound, a vanadium-containing compound, a copper-containing compound and an antimony-containing compound with water, then drying and calcining a resulting mixture, in which a catalytically-active element composition is kept constant but material source compounds are made to vary in type to give composite metal oxides having a different activity. | 2013-08-22 |
20130217916 | Synthesis of Tripodal Bisphosphonate Derivatives Having an Adamantyl Basic Framework for Functionalizing Surfaces - The present invention describes tripodal catechol derivatives with an adamantyl basic framework for the functionalisation of surfaces, and methods for their production and use. A fourth remaining position of the adamantane skeleton is suitable to be optionally functionalised by so-called click reactions, for example with biomolecules, polyethylene glycol or active agents. | 2013-08-22 |
20130217917 | CHOLINE ANALOGS AND CHEMICAL SYNTHESIS THEREOF - A method of making a betaine aldehyde, comprising ozonizing an allyl trimethylammonium to form the betaine aldehyde. | 2013-08-22 |
20130217918 | PROCESSES FOR THE PREPARATION OF (S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHANESULFONYLETHYLAMINE - Provided herein are new processes for the preparation of aminosulfone intermediates for the synthesis of 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, which is useful for preventing or treating diseases or conditions related to an abnormally high level or activity of TNF-α. Further provided herein are processes for the commercial production of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine. | 2013-08-22 |
20130217919 | ASYMMETRIC SYNTHETIC PROCESSES FOR THE PREPARATION OF AMINOSULFONE COMPOUNDS - Processes for synthesizing aminosulfone compounds are provided. Aminosulfone compounds obtained using methods provided herein are useful in production or synthesis of sulfone group containing isoindoline based compounds. | 2013-08-22 |
20130217920 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS - This invention relates to methods, which provide access to [F-18]fluoropegylated (aryl/heteraryl vinyl)-phenyl methyl amine derivatives. | 2013-08-22 |
20130217921 | "PROCESSES FOR PRODUCING PHENOL" - In a process for producing phenol and cyclohexanone, a feed comprising cyclohexylbenzene is oxidized to produce an oxidation reaction product comprising cyclohexyl-1-phenyl-1-hydroperoxide. At least a portion of the oxidation reaction product is then cleaved to produce a cleavage reaction product comprising phenol, cyclohexanone, and at least one contaminant. At least a portion of the cleavage reaction product is contacted with an acidic material to convert at least a portion of the at least one contaminant to a converted contaminant and thereby produce a modified reaction product. | 2013-08-22 |
20130217922 | Processes for Producing Phenol - Disclosed herein is a process for producing phenol. The process includes oxidizing at least a portion of a feed comprising cyclohexylbenzene to produce an oxidation composition comprising cyclohexyl-1-phenyl-1-hydroperoxide. The oxidation composition may then be cleaved in the presence of an acid catalyst to produce a cleavage reaction mixture comprising the acid catalyst, phenol and cyclohexanone. At least a portion of the cleavage reaction mixture may be neutralized with a basic material to form a treated cleavage reaction mixture. In various embodiments, the treated cleavage reaction mixture contains no greater than 50 wppm of the acid catalyst or no greater than 50 wppm of the basic material. | 2013-08-22 |
20130217923 | NOVEL STRUCTURED CATALYST - The present invention relates to novel structured catalysts based on sintered metal fibers (SMF) coated by a basic oxide layer with Pd-nanoparticles, to reactions of organic compounds with hydrogen in the presence of said catalyst and an organic base as well as to vitamins, carotinoids, perfume ingredients, and/or food or feed ingredients prepared by using this reaction. | 2013-08-22 |
20130217924 | METHOD FOR PRODUCING HIGHER ALCOHOL - Provided is a method of producing a higher alcohol, comprising a step of hydrogenating a lipid obtained by culturing | 2013-08-22 |
20130217925 | Production of Ethanol From Methanol - A process for converting methanol to ethanol which comprises reacting methanol and carbon monoxide in the presence of a catalyst to produce a product comprising at least 25 mole % methyl acetate and, in some instances, acetic acid. The acetic acid then is reacted with at least one alcohol to produce at least one acetate selected from methyl acetate, ethyl acetate, and butyl acetate. The at least one acetate (if produced) and the methyl acetate produced as a result of reacting methanol and carbon monoxide then are hydrogenated to produce ethanol. Syngas may be produced from biomass to produce all or a portion of the methanol, hydrogen, and carbon monoxide requirements for the process. | 2013-08-22 |
20130217926 | COMPOSITE MEMBRANE - A method of forming a composite membrane ( | 2013-08-22 |
20130217927 | Process for Preparing R-1234yf by Base Mediated Dehydrohalogenation - The invention relates to a process for preparing 2,3,3,3-tetrafluoropropene (CF | 2013-08-22 |
20130217928 | PROCESS FOR PRODUCING 2,3,3,3-TETRAFLUOROPROPENE - This invention provides a process for producing 2,3,3,3-tetrafluoropropene, the process comprising: (1) a first reaction step of reacting hydrogen fluoride with at least one chlorine-containing compound selected from the group consisting of a chloropropane represented by Formula (1): CClX | 2013-08-22 |
20130217929 | Azeotrope-Like Composition of Hexafluoropropane, Hexafluoropropene and Hydrogen Fluoride - The present invention relates to an azeotropic or azeotrope-like mixture consisting essentially of 1,1,1,2,3,3-hexafluoropropane, hexafluoropropene and hydrogen fluoride. | 2013-08-22 |
20130217930 | Use of Self-Crosslinked Siloxanes for the Defoaming of Liquid Hydrocarbons - The present invention relates to the use of compositions comprising the following components: A, a polymer obtainable through hydrosilylation of a siloxane having SiH functions and having vinyl functions with another unsaturated compound, and D, platinum-group-metal atoms or platinum-group-metal ions, as antifoam for hydrocarbons, and also for suppressing or reducing the formation of foam or for the destabilization of foam. | 2013-08-22 |
20130217931 | HYDROCARBON-FORMING OXIDATIVE DECARBONYLASE ENZYME, HYDROCARBONS PRODUCED THEREBY, AND METHOD OF USE - The present disclosure relates to oxidative decarbonylase enzymes, methods of making hydrocarbons with such enzymes, hydrocarbons produced therefrom and uses thereof. More particularly, the present disclosure relates to isolated polypeptide sequences that are cytochrome P450 enzymes with oxidative decarbonylase activity and methods of their use to generate hydrocarbon products, such as biofuels. | 2013-08-22 |
20130217932 | Biorefinery for conversion of carbothdrates and lignocellulosics via primary hydrolysate cmf to liquid fuels - A method of making alkanes from lignocellulosic sources of C5 and C6 sugars. Suitable biomass feedstocks are converted into alkane-based fuels such as diesel and jet fuel blendstocks. Sugar monomers from the feedstocks are converted to chlormethylfurfural (CMF) with a levulinic acid (LA) byproduct. The CMF and LA are converted to ethyl levulinate (EL) and hydroxymethylfurfural (HMF), which are then combined into longer chain molecules via aldol condensation reactions. The condensation products are partially or fully saturated by mild hydrotreating, followed by deoxygenation to form alkanes with boiling ranges suitable for use as liquid fuels. | 2013-08-22 |
20130217933 | PROCESSES AND HYDROCARBON PROCESSING APPARATUSES FOR PREPARING MONO-OLEFINS - Processes and hydrocarbon processing apparatuses for preparing mono-olefins are provided. An exemplary process includes separating a hydrocarbon feed into a first fraction of carbon-containing compounds having less than or equal to 5 carbon atoms and a second fraction of compounds that have a lower vapor pressure than those in the first fraction. Dienes and/or acetylenes from the first fraction are selectively hydrogenated into corresponding mono-olefins. Paraffins from the first fraction are converted into corresponding mono-olefins. The converted mono-olefins are contact cooled with an impurity-containing liquid hydrocarbon stream, with the impurities in the impurity-containing liquid hydrocarbon stream having a lower vapor pressure than compounds in the first fraction. The dienes and/or acetylenes from the first fraction are selectively hydrogenated prior to converting the paraffins from the first fraction into mono-olefins and after separating the first fraction from the hydrocarbon feed. | 2013-08-22 |
20130217934 | PROCESS FOR PRODUCING AROMATIC HYDROCARBONS AND ETHYLENE - The present invention provides a process for producing aromatic hydrocarbons and ethylene, comprising: a. contacting a lower alkane feed comprising at least one of ethane, propane and butane with an aromatic hydrocarbon conversion catalyst within an alkane-to-aromatic zone to obtain at least hydrogen and aromatic reaction products, including at least benzene; b. converting an oxygenate feedstock in an oxygenate-to-olefin zone to obtain olefins, including at least ethylene; wherein at least part of the oxygenate feedstock is obtained by providing at least part of the hydrogen obtained in step a) and a feed containing carbon monoxide and/or carbon dioxide to an oxygenate synthesis zone and synthesizing oxygenates. In another aspect the invention provides an integrated system for aromatic hydrocarbons and ethylene and the use of hydrogen obtained from a process to convert lower alkanes to benzene to produce an oxygenate feed for an oxygenate-to-olefin process. | 2013-08-22 |
20130217935 | PROCESS TO MAKE OLEFINS FROM METHANOL AND ISOBUTANOL - The present invention relates to a process for making essentially ethylene and propylene comprising:
| 2013-08-22 |
20130217936 | Method of Making Catalyst, Catalyst Made Thereby and Use Thereof - The invention concerns a method of making a catalyst adapted for isomerization of xylenes. | 2013-08-22 |
20130217937 | Processes for The Reduction of Alkylation Catalyst Deactivation Utilizing Stacked Catalyst Bed - Alkylation systems and methods of minimizing alkylation catalyst regeneration are discussed herein. The alkylation systems generally include a preliminary alkylation system adapted to receive an input stream including an alkyl aromatic hydrocarbon and contact the input stream with a first preliminary alkylation catalyst disposed therein to form a first output stream. The first preliminary alkylation catalyst generally includes a Y zeolite. The systems further include a first alkylation system adapted to receive the first output stream and contact the first output stream with a first alkylation catalyst disposed therein and an alkylating agent to form a second output stream. | 2013-08-22 |
20130217938 | PROCESSES FOR CONVERTING HYDROGEN SULFIDE TO CARBON DISULFIDE - Processes for forming carbon disulfide from a gas stream containing hydrogen sulfide. A gaseous stream comprising lower molecular weight alkanes and hydrogen sulfide may be contacted with sufficient bromine at a temperature of from about 250° C. to about 530° C. to convert substantially all of said hydrogen sulfide to carbon disulfide. The gaseous stream may contain from about 0.001 to about 20 mol % hydrogen sulfide. The molar ratio of bromine to hydrogen sulfide may be about 2:1. | 2013-08-22 |
20130217939 | PROCESS FOR PRODUCING LIGHT OLEFINS BY USING A ZSM - 5 - BASED CATALYST - The present invention relates to a catalyst composition useful in a process for producing lower olefins from a oxygenate feedstream, a process for producing said catalyst composition and a process for producing lower olefins comprising contacting a oxygenate feedstream with the catalyst composition M | 2013-08-22 |
20130217940 | Alkylation of Benzene and/or Toluene with Methanol - The present inventors have surprisingly discovered that paraxylene selectivity is found to increase as the amount of coke on catalyst increases. In embodiments the paraxylene selectivity and productivity is maximized by controlling the amount of coke on the catalyst while maintaining xylene yield at an acceptable value. The control of coke may be achieved by one or a combination of the following techniques: increasing catalyst on-oil time, decreasing catalyst residence time in the regenerator, reducing the air or oxygen supply to the regenerator, and decreasing catalyst circulation rate, or a combination thereof. | 2013-08-22 |
20130217941 | PROCESS FOR OLIGOMERIZATION OF OLEFINS THAT USES A CATALYTIC COMPOSITION THAT COMPRISES AN ORGANOMETALLIC COMPLEX THAT CONTAINS AN ALKOXY LIGAND THAT IS FUNCTIONALIZED BY A HETEROATOM - The invention describes a process for oligomerization of olefins into compounds or into a mixture of compounds of general formula CpH2p with 4≦p≦80 that employs a catalytic composition that comprises at least one organometallic complex of an element of group IV that is selected from among titanium, zirconium, or hafnium, whereby said organometallic complex contains at least one alkoxy-type ligand that is functionalized by a heteroatom that is selected from among nitrogen, oxygen, phosphorus or sulfur, or by an aromatic group. | 2013-08-22 |
20130217942 | PRODUCTION OF ISOPRENE FROM ISO-BUTANOL - The present invention is a process to make isoprene comprising:
| 2013-08-22 |
20130217943 | DEHYDRATION OF ALCOHOLS ON ACIDIC CATALYSTS - The present invention is a process for the dehydration of an alcohol having at least 2 carbon atoms to make the corresponding olefin, comprising:
| 2013-08-22 |
20130217944 | REMOVAL OF SULFUR COMPOUNDS FROM A GAS STREAM - A method and apparatus for eliminating COS and/or CS | 2013-08-22 |
20130217945 | PROCESSES AND SYSTEMS FOR TREATING AROMATIC FEED INCLUDING AN AROMATIC COMPONENT AND NITROGEN-CONTAINING IMPURITIES, AND PROCESSES AND SYSTEMS FOR PREPARING A REACTION PRODUCT OF THE AROMATIC COMPONENT - Processes and systems for treating an aromatic feed comprising an aromatic component and nitrogen-containing impurities, as well as processes and systems for preparing a reaction product of an aromatic component from an aromatic feed comprising the aromatic component and nitrogen-containing impurities, are provided herein. In an embodiment, a process for treating an aromatic feed comprising an aromatic component and nitrogen-containing impurities includes adsorbing a portion of the nitrogen-containing impurities from the aromatic feed to produce a treated aromatic feed comprising the aromatic component and residual nitrogen-containing impurities. The treated aromatic feed and water are mixed to produce a hydrated aromatic feed. A purified aromatic feed and a water component are distilled from the hydrated aromatic feed in a distillation stage, wherein the water component comprises residual nitrogen-containing impurities from the treated aromatic feed and wherein the purified aromatic feed comprises the aromatic component. | 2013-08-22 |
20130217946 | CHARGED PARTICLE TREATMENT, RAPID PATIENT POSITIONING APPARATUS AND METHOD OF USE THEREOF - The invention comprises a charged particle beam, rapid patient positioning system including steps of: positioning a patient relative to a table in a substantially vertical orientation, optionally constraining motion of the patient with one or more constraints, transitioning the table through a semi-vertical orientation, such as with a robot arm, and orientating the patient and table in a substantially horizontal orientation, such as in a position for tumor therapy. Preferably, the robot arm is in common with an arm used to move the patient in traditional proton therapy. Optionally, the robot arm is used to re-orientate the patient into a substantially vertical orientation at the conclusion of a charged particle therapy session. | 2013-08-22 |
20130217947 | Hybrid Ultrasound-Guided Superficial Radiotherapy System and Method - Systems, method and devices for detecting, analyzing and treating lesions, such as skin cancer are disclosed. Such a system can include a high-frequency ultrasound imaging device to image a lesion. The system can also include a processor that executes instructions stored in memory to perform operations, and the operations can include receiving a plurality of images of the lesion from the high-frequency ultrasound imaging device, rendering a three dimensional model of the lesion using the plurality of images from the high-frequency ultrasound imaging device and determining a treatment dosimetry based on the three dimensional model of the lesion. The system can also include a radiotherapy device to provide radiotherapy treatment to the lesion, where the radiotherapy treatment is based on the treatment dosimetry. | 2013-08-22 |
20130217948 | Advanced Radiotherapy Treatment Planning Optimization - A method of radiotherapy treatment planning is described. A planned target volume is identified for radiotherapy treatment and at least one volume of interest is identified. The mass, density, and total deposited energy contained in the planned target volume and the volumes of interest are identified and dose objectives are determined. At least one of the objectives is a function of the identified mass, density, or deposited energy. A composite objective function is determined using the dose objectives for the planned target volume and the volumes of interest. A near optimal solution to the composite objective function is determined to produce a radiotherapy treatment plan. | 2013-08-22 |
20130217949 | COMBINATORIAL METHODS AND COMPOSITIONS FOR TREATMENT OF MELANOMA - The invention relates to combining targeted therapies with selected chemotherapeutics for the treatment of melanoma. The invention provides a method for inducing apoptosis in a melanoma tumor cell by reducing Akt3 activity, a method for inducing apoptosis in a melanoma tumor cell comprising contacting a melanoma tumor cell with an agent that reduces Akt3 activity to restore normal apoptotic sensitivity to a melanoma tumor cell, allowing a lower concentration of chemotherapeutic agents resulting in decreased toxicity to a patient. Also disclosed is a method for treating a melanoma comprising administering an agent that reduces Akt3 activity and an agent that reduces V599E B-Raf activity, thereby treating a melanoma tumor. | 2013-08-22 |
20130217950 | THERAPEUTIC APPARATUS FOR HEATING A SUBJECT - A therapeutic apparatus ( | 2013-08-22 |
20130217951 | 7-(1,2,3-TRIAZOL-4-YL) PYRROLO [2,3-B] PYRAZINE DERIVATIVES - Compounds of the formula (I), in which R | 2013-08-22 |
20130217952 | OPHTHALMIC ORBITAL SURGERY APPARATUS AND METHOD AND IMAGE-GUIDED NAVIGATION SYSTEM - A flexible endoscope for ophthalmic orbital surgery includes a flexible probe housing having a proximal end, a distal end and a lumen extending between the proximal end and the distal end. The endoscope also includes an image fiber disposed in the lumen that communicates image information from the distal end of the flexible probe, a purge fluid/gas port disposed at the proximal end of the flexible probe that accepts purge fluid/gas and a purge fluid/gas conduit disposed in the lumen and in fluid communication with the purge fluid/gas port. The fluid/gas conduit delivers purge fluid/gas to the distal end of the endoscope. The endoscope also includes an access conduit disposed in the lumen that receives one of an ablation instrument, a coagulating instrument and a medication delivery instrument. | 2013-08-22 |
20130217953 | FLUID PUMPING VENTRICULAR ASSIST DEVICE AND COMPONENTS WITH STATIC SEAL - A ventricular assist device (VAD) having static seal structure for a pump housing which includes a support structure, a first sealing element, and a second sealing element. The support structure circumscribes a pump chamber and includes a first sealing surface, an opposing second sealing surface, and a fluid transfer end interposed between the sealing surfaces. The support structure provides a fluid flow path running through the fluid transfer end and into the pump chamber via an inlet bore and from the pump chamber back through the fluid transfer end via an outlet bore. The first sealing element is disposed on the first sealing surface, and the second sealing element is disposed on the second sealing surface. The sealing elements are configured for forming sealing interfaces in the pump housing, establishing a static seal that isolates the pump chamber from an environment external to the fluid pump housing. | 2013-08-22 |
20130217954 | ADJUSTABLE MEDICAL ASSEMBLY FOR IMPLANT TENSION ADJUSTMENT - The present invention discloses a medical assembly and method to deliver and place a bodily implant inside a patient's body. The medical assembly includes an insertion tool such that a portion of the insertion tool defines a lumen. The medical assembly further includes a carrier configured to be coupled to the insertion tool and including a passageway. The medical assembly also includes a flexible elongate member configured to pass through the passageway of the carrier and the lumen. The elongate member is also configured to be coupled to the bodily implant such that a portion of the elongate member between the bodily implant and the carrier defines a length. | 2013-08-22 |
20130217955 | SYSTEM AND METHOD FOR TREATMENT OF ANAL INCONTINENCE AND PELVIC ORGAN PROLAPSE - Using a sling that includes a central portion and at least two arms extending from the central portion, a method of treating anal incontinence may include positioning the central portion posteriorly to the rectum and/or anus of a subject, and extending each arm of the sling to a respective obturator region. Using a sling having the same or similar structure, a method of treating pelvic organ prolapse may include positioning the central portion beneath the ano-rectum of a subject, and extending each arm of the sling to a respective thigh incision near the obturator region. | 2013-08-22 |
20130217956 | Minimally Invasive Lung Volume Reduction Devices, Methods, and Systems - A lung volume reduction system is disclosed comprising an implantable device adapted to be delivered to a lung airway of a patient in a delivery configuration and to change to a deployed configuration to bend the lung airway. The invention also discloses a method of bending a lung airway of a patient comprising inserting a device into the airway in a delivery configuration and bending the device into a deployed configuration, thereby bending the airway. | 2013-08-22 |
20130217957 | DEVICES AND METHODS FOR THE ENDOLUMENAL TREATMENT OF OBESITY - A surgical method for treating obesity by reducing the size and/or function of the stomach includes forming at least two plications or tissue folds in tissue of a patient using anchor assemblies having a loop. The plications are then optionally allowed to heal. A loop suture or wire is threaded through the loops. The loop suture is then tensioned to draw the plications towards each other. The loop suture is then secured via a knot or a cinch. When the method is performed in the stomach for treatment of obesity, forming the plications reduces the volume of the stomach. Drawing the plications together creates a contracted tissue area which further reduces the volume of the stomach. Additional plications may also be formed and drawn together with the same loop suture, or with a different loop suture. | 2013-08-22 |
20130217958 | Surgical Needle Device - Various surgical introducer needle and anchor systems are provided. The systems can include an introducer needle and a tissue support implant or sling device. The implant device can include one or more anchoring devices. The introducer needle device can include a handle assembly and a needle assembly. The needle assembly can include a generally hollow needle, and a wire traversable therein. The wire can include a distal tip adapted to selectively retract or withdraw from the engaged anchoring device upon deployment of the anchor and/or implant. | 2013-08-22 |
20130217959 | Methods and Apparatus Providing Suction-Assisted Tissue Engagement Through a Minimally Invasive Incision - Suction-assisted tissue-engaging devices, systems, and methods are disclosed that can be employed through minimal surgical incisions to engage tissue during a medical procedure through application of suction to the tissue through a suction member applied to the tissue. A shaft is introduced into a body cavity through a first incision, and a suction head is attached to the shaft via a second incision. The suction head is applied against the tissue by manipulation of the shaft and suction is applied to engage the tissue while the medical procedure is performed through the second incision. A system coupled to the shaft and a fixed reference point stabilizes the shaft and suction head. When the medical procedure is completed, suction is discontinued, the suction head is detached from the shaft and withdrawn from the body cavity through the second incision, and the shaft is retracted through the first incision. | 2013-08-22 |
20130217960 | APPLICATOR HAVING A COLOR GRADIENT - An applicator having a color gradient. The applicator includes an outer member having a first end, a second end disposed opposite the first end, a longitudinal axis, a length measured along the longitudinal axis, and an exterior surface. The outer member further includes a color gradient extending along at least a portion of the length from a first region to a second region, the color gradient being visible by a user viewing the exterior surface of the outer member. | 2013-08-22 |
20130217962 | CAPSULE ENDOSCOPE SYSTEM, OPERATING METHOD OF IMAGE DISPLAY, AND COMPUTER-READABLE RECORDING MEDIUM - A capsule endoscope system includes: a capsule endoscope including a first and a second imaging units; an image display that displays images captured by the first and second imaging units; a control unit that determines a moving direction of the capsule endoscope during imaging, specifies one of the imaging units which faces the moving direction of the capsule endoscope during imaging, and determines the posture of the capsule endoscope; and a display control unit that generates a display screen, arranges the image captured by the imaging unit facing the moving direction in a first display region in the display screen, arranges the image captured by the other imaging unit in a second display region in the display screen, and changes the positions of the first and second display regions according to the determination result of the position of the capsule endoscope. | 2013-08-22 |
20130217963 | ENDOSCOPE AUXILIARY INSTRUMENT AND ENDOSCOPE - An endoscope auxiliary instrument includes a hood, a hood cover that is provided at a distal end portion of an insertion portion of an endoscope and that movably holds the hood along an axial direction of the insertion portion, and a wire fixing portion. The wire fixing portion causes the hood to protrude/retract at the distal end portion in a direction parallel to an axis of the hood that is a direction along an axial direction of the insertion portion, and fixes a wire that, when the hood receives a force in a proximal end direction in a state in which the hood protrudes in a distal end direction of the distal end portion, generates a return force that causes the hood to returns to the protruding state. | 2013-08-22 |
20130217964 | EXPANSION CATHETER - Disclosed herein is an expansion catheter including: an expansion body which can be expanded; an elongate main body to a distal section of which the expansion body is attached; and an imaging section by which the expansion body is imaged from a proximal side thereof. | 2013-08-22 |
20130217965 | Endoscope Apparatus - An endoscope apparatus includes an objective optical system mounted at a distal end portion of an endoscope, which is inserted into a tube cavity, and configured to form an image of an object, the objective optical system including a focusing lens movable in an optical axis direction, a solid-state image pickup device for color image pickup configured to pick up the image formed by the objective optical system, a color separation filter being arranged for each pixel in the solid-state image pickup device, a focus adjusting mechanism configured to move the focusing lens and automatically adjust the objective optical system to a focus position in a focused state, a moving range switching section configured to perform switching of a moving range of the focusing lens, a moving range limiting section configured to limit the moving range in association with the switching by the moving range switching section, and the like. | 2013-08-22 |
20130217966 | ENCAPSULATED ENDOSCOPE SYSTEM IN WHICH ENDOSCOPE MOVES IN LUMEN BY ITSELF AND ROTATION OF IMAGE OF REGION TO BE OBSERVED IS CEASED - An encapsulated endoscope system in accordance with the present invention comprises: an encapsulated endoscope that rotates to develop a thrust; a controller that moves the encapsulated endoscope in an intended direction of advancement; an imaging unit incorporated in the encapsulated endoscope; and an image processing unit that receives image data sent from the imaging unit, and produces an image, which results from rotation of the received image data, according to the rotational phase of the encapsulated endoscope. | 2013-08-22 |
20130217967 | METHOD OF USER INTERFACES FOR ELECTROSURGICAL TOOLS IN ROBOTIC SURGICAL SYSTEMS - A method for a minimally invasive surgical system is disclosed including capturing camera images of a surgical site; generating a graphical user interface (GUI) including a first colored border portion in a first side and a second colored border in a second side opposite the first side; and overlaying the GUI onto the captured camera images of the surgical site for display on a display device of a surgeon console. The GUI provides information to a user regarding the first electrosurgical tool and the second tool in the surgical site that is concurrently displayed by the captured camera images. The first colored border portion in the GUI indicates that the first electrosurgical tool is controlled by a first master grip of the surgeon console and the second colored border portion indicates the tool type of the second tool controlled by a second master grip of the surgeon console. | 2013-08-22 |
20130217968 | ENDOSCOPE APPARATUS, METHOD, AND COMPUTER READABLE MEDIUM - An endoscope apparatus comprising an irradiating section that switches over time between irradiating a target with light in a first wavelength region and light in a second wavelength region; a light receiving section that receives returned light from the target; a movement identifying section that identifies movement of the target, based on an image of the target captured using returned light from the target irradiated by light in the first wavelength region; a control section that that predicts timings at which a phase of the movement of the target is a predetermined phase, based on the movement identified by the movement identifying section, and causes the irradiating section to emit light in the second wavelength region at the predicted timings; and an image generating section that generates an image of the target based on the returned light received by the light receiving section at the predicted timings. | 2013-08-22 |
20130217969 | ENDOSCOPE DEVICE - In a tip face of an insertion part of an endoscope, gas is discharged from a plurality of air supply ports formed around an observation window, and air currents are generated. This removes suspended matter, such as oil particles and fat particles, from an imaging visual field. The interval between adjacent air supply ports of the air supply port is specified so that the gas around air currents is caught in the air currents by the air currents without being directed towards the imaging lens. The surrounding gas by the air currents being discharged is pulled in the imaging direction along with the air currents. Since the surrounding gas induced by the air currents is prevented from being induced in the direction of the imaging lens, the imaging lens can be prevented from being contaminated by an unnecessary object. | 2013-08-22 |
20130217970 | APPARATUS AND METHODS FOR CLEANING THE LENS OF AN ENDOSCOPE - An apparatus for cleaning a lens, or one or more lenses, of an endoscopic camera while the endoscope is deployed in a patient during a medical procedure, such as a minimally invasive procedure, or a therapeutic or diagnostic procedure, is disclosed. The cleaning apparatus generally includes a conduit having a fluid delivery port, an alignment system, and a flexible supply tube to fluidly connect the conduit to one or both of a source of a fluid and a suction device. | 2013-08-22 |
20130217971 | INTUBATION GUIDE - Apparatuses for guiding an endotracheal tube during intubation and associated methods of their use; the apparatuses formed to contain a plastic element able to hold deformations so as to conform the apparatus to the shape of a patient's endotracheal airway. The plastic element has sufficient give so as to minimize traumatic engagement with the inner surface of the airway lumen. Methods for using the apparatuses exploit indirect visualization where the person performing the intubation can shape the apparatuses so as to place the distal end into the field of view of the indirect visualization instrument even with minimal alignment of the patient's airway. | 2013-08-22 |